Vol 4, No 4 (December 2013): Journal of Gastrointestinal Oncology
Intensifying local radiotherapy for pancreatic cancer—who benefits and how do we select them?
New possibilities and potential benefits for local control in locally recurrent pancreatic cancer
Intrapancreatic accessory spleen presenting as a pancreatic mass
Metachronous pancreatic metastasis of an ovarian serous papillary adenocarcinoma after 8 years
Letter to the Editor
RE: Upper gastrointestinal complications associated with gemcitabine-concurrent proton radiotherapy for inoperable pancreatic cancer. J Gastroenterol. 2013; (E-pub only).